A5004047153- Advanced Radiotherapy Techniques
- Advances in Oncology and Radiotherapy
- Breast Cancer Treatment Studies
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Advanced X-ray and CT Imaging
- Dermatologic Treatments and Research
- Prostate Cancer Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Ovarian cancer diagnosis and treatment
- Ultrasound and Hyperthermia Applications
- Radiopharmaceutical Chemistry and Applications
- Effects of Radiation Exposure
- Lung Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
Universitätsklinikum Erlangen
2022-2023
Friedrich-Alexander-Universität Erlangen-Nürnberg
2022-2023
Comprehensive Cancer Center Erlangen
2022-2023
In order to evaluate organ-at-risk (OAR) doses in external-beam-accelerated partial-breast irradiation (APBI) compared standard whole-breast (WBI) after breast-conserving surgery. Between 2011 and 2021, 170 patients with early breast cancer received APBI within a prospective institutional single-arm trial. The prescribed dose the planning treatment volume was 38 Gy 10 fractions on consecutive working days. OAR for contralateral breast, ipsilateral, contralateral, whole lung, heart, left...
In order to evaluate the risk for radiation-associated symptomatic pneumonitis in a prospective external beam accelerated partial breast irradiation (APBI) trial, between 2011 and 2021, 170 patients with early stage cancer were enclosed trial. Patients eligible study participation if they had histologically confirmed or an exclusive ductal carcinoma situ (DCIS), tumor size ≤3 cm, free safety margins ≥2 mm, no involved axillary lymph nodes, bed clips, ≥50 years old. received APBI 38 Gy 10...